Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.

Clicks: 358
ID: 100766
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 27 articles by views in cancer immunology, immunotherapy : cii

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
bellone2020cancercancer Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bellone, Matteo;Brevi, Arianna;Bruzzì, Stefania;Consonni, Michela;De Santis, Francesca;Di Lullo, Giulia;Majorini, Maria Teresa;Pastò, Anna;Amadori, Alberto;Bregni, Marco;Di Nicola, Massimo;Calabrò, Luana;Ferrucci, Pier Francesco;Proietti, Enrico;Colombo, Mario Paolo;Russo, Vincenzo;
Journal cancer immunology, immunotherapy : cii
Year 2020
DOI
10.1007/s00262-020-02502-1
URL
Keywords
immunotherapy cancer vaccines adoptive immunotherapy checkpoint blockade agents nibit targeted therapies

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.